Ethos Technologies

The company listed on the Nasdaq under the ticker symbol LIFE

Ethos IPO: US insurance marketplace goes public

York Space Systems

The company goes public on the New York Stock Exchange under the ticker YSS

York Space Systems IPO: Shares of Pentagon space contractor begin trading

Picpay Holdings


The company goes public on the Nasdaq under the ticker PICS

Picpay IPO: shares of one of the largest digital banks in Brazil become available

Corvus Pharmaceuticals, Inc.

Trinseo PLC

Freedom Broker has named the two stocks from the smid-cap-tracking Russell 2000 index with best and worst performance from January 9 through January 22. The former was recorded by Corvus Pharmaceuticals, which is developing a drug for atopic dermatitis, while the worst performer was Trinseo, a producer of specialty materials for the construction and automotive industries.

Freedom names biggest small-cap winner and loser in last two weeks

EquipmentShare.com Inc.

EquipmentShare IPO: Shares of construction equipment retailer begin trading

BitGo Holdings, Inc.

BitGo IPO: one of the largest cryptocurrency wallet providers went public

SMA Solar Technology AG

Sixt SE

thyssenkrupp nucera AG & Co. KGaA

Vossloh AG

Wacker Neuson SE

German small-cap stocks offer an opportunity to participate in the transformation of the German economy particularly in terms of mobility and green energy. German GDP is <a href="https://www.reuters.com/markets/europe/german-economy-grow-after-two-straight-years-contraction-ifw-says-2025-06-12/?utm_source=chatgpt.com%23:~:text=The%2520Leibniz%2520Institute,new%2520German%2520government.%2522">projected</a>&nbsp;to grow roughly 1.1-1.5% in 2026, a gradual recovery from the near-stagnation of 2024-2025. Fiscal support is&nbsp;channeled  through funds for decarbonization, green mobility, and infrastructure, supporting demand for rail transport, renewable energy, and low-emission equipment.

Betting on the green economy: Five interesting German small caps from Freedom24 

Contango Ore, Inc.

Dolly Varden Silver Corporation

Gold exploration and production company Contango ORE and silver miner Dolly Varden Silver <a href="https://www.contangoore.com/press-release/contango-ore-and-dolly-varden-silver-announce-merger-to-create-a-new-north-american-high-grade-mid-tier-silver-gold-producer-and-developer">announced</a>&nbsp;a merger in late December. The transaction will combine their assets in Alaska and British Columbia. Below is a summary of what investors need to know about the deal, the outlook for the combined company, and its key projects.

Gold and silver combine: Breaking down the Contango ORE/Dolly Varden merger

NovaBay Pharmaceuticals, Inc.

The Oncology Institute, Inc.

Relmada Therapeutics, Inc.

Palvella Therapeutics, Inc.

Avino Silver & Gold Mines Ltd.

In 2025, small-cap stocks generally lagged their large-cap peers. While the <a href="https://finance.yahoo.com/quote/%5EGSPC/">S&amp;P 500</a>&nbsp;index rose 16.6% over the year, the <a href="https://finance.yahoo.com/quote/%5ERUT/">Russell 2000</a>, which tracks smaller companies, gained 11.1%. Some small caps, however, delivered explosive returns, with share prices rising more than 600%, notes Freedom Broker, whose screen covered companies with market capitalizations between $300 million and $2 billion.

600% and above: Freedom spotlights five small caps with super-high returns in 2025

NioCorp Developments Ltd.

Shares of NioCorp Developments, which is engaged in exploration and development of mineral deposits in North America, have the potential to rise about 35%, Freedom Capital Markets analyst&nbsp;Vitaly Kononov argued in a recent initiation report on the company. He attributes the upside to long-term demand for critical minerals in the U.S. and progress at NioCorp’s flagship project, which is moving into the construction phase.

Freedom initiates on U.S. rare-earth miner NioCorp, sees 35% upside

Aktis Oncology, Inc.

Preliminary trading in shares of US biotech company Aktis Oncology has started in the Freedom trading system for clients. The startup, in which pharma giant Eli Lilly and major industry investor MPM BioImpact have invested, develops drugs with radioactive isotopes to treat cancerous tumors. Later Friday, Aktis Oncology securities will appear on the Nasdaq exchange under the ticker AKTS.

Aktis Oncology IPO: Shares of the developer of radiopharmaceuticals for cancer have started trading

Meta Platforms, Inc.

NVIDIA Corporation

BlackRock, Inc.

Freedom has released its top U.S. stock picks for 2026, making sweeping changes to last year’s <a href="https://oninvest.com/article/freedom-broker-obnovil-spisok-lucsih-investidej-na-2025-god">lineup</a>. Most prior picks have been dropped, while a new group of stocks has emerged as macroeconomic conditions, corporate earnings trajectories, and sector dynamics have shifted.

Freedom Holding